Product Information
AMITRIPTYLINE HCL 150 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.2921 per EA under NDC 16729017601. Its NADAC has been published 589 times since Feb 11, 2015.
FDA first approved this application on Jun 4, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the AMITRIPTYLINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729017601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202446FDA Approved
6/4/2014
TE Code
AB
On Market Since
12/26/2014
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 150 MG TAB has been published 589 times since Feb 11, 2015, and over the history we have for it it has declined 82.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2921 per EA |
|---|---|
| All-time high | $1.6689 (Feb 11, 2015) |
| All-time low | $0.1749 (Dec 21, 2022) |
| 52-week high | $0.2970 |
| 52-week low | $0.2222 |
| Median price | $0.7540 |
| Average price | $0.8298 |
| Largest weekly change | +55.6% (Mar 22, 2023) |
| Weeks tracked | 589 |
| Tracking since | Feb 11, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
+6.3%
1Y
+31.4%
3Y
+36.2%
5Y
-57.7%
All
-82.5%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the AMITRIPTYLINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 150 MG TAB, manufactured by Accord Healthcare Inc., is $0.2921 per EA (NDC 16729017601), effective May 20, 2026.
How has the price of AMITRIPTYLINE HCL 150 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has declined 82.5%. It has been tracked across 589 weekly CMS publications since Feb 11, 2015.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 150 MG TAB?
Since Feb 11, 2015, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has ranged from a low of $0.1749 (Dec 21, 2022) to a high of $1.6689 (Feb 11, 2015), with a median of $0.7540 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 150 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of AMITRIPTYLINE HCL 150 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMITRIPTYLINE HCL 150 MG TAB?
AMITRIPTYLINE HCL 150 MG TAB (NDC 16729017601) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.